Blood Gas and Electrolyte Analyzers: A Global Strategic Business Report
San Jose, California (PRWEB) March 26, 2012
Follow us on LinkedIn – Increase in global aging population is resulting in an increase in patients receiving critical care in emergency departments, intensive care units, and operation rooms. This in turn boosts market potential for blood gas and electrolyte analyzers. As blood gas testing has been of critical importance for several years now, market participants are fully aware of the needs of the critical care testing, and offer devices that are user-friendly, and provide quick and accurate results. In addition, the market is also characterized by the reduction in size of the analyzers, and the emergence of multi-parameter monitoring device driven by expanding test menus.
Point-of-care testing constitutes yet another major transformation in the blood gas and electrolyte analyzers market. Modern day blood analysis systems are witnessing skyrocketing penetration. Technology has often been a cornerstone for the success of blood gas analyzers, as medical practitioners and patients are inclining towards timely and effective clinical results. Introduction of point-of-care analyzers exemplified this strategy, which is further primed to factor in competition in the blood gas analyzer market. The innovation binge has brought in newfound devices into the market that resulted in medical research institutes swerve from Benchtop analyzers to POC devices. Device miniaturization & sophistication, and ease-of-use of these point-of-care systems enabled them to corner a remarkable success in the blood gas analyzer market of late. Also, cost cut-downs rampant in the industry espoused the growing penetration for POC devices in decentralized laboratories.
The United States and Europe constitute the largest regional markets worldwide, as stated by the new market research report on Blood Gas and Electrolyte Analyzers. Currently, people over 65 years of age constitute about 12% of the US population and by the year 2030, this is expected to cross 15%. With no dearth in patients requiring critical care in the US, the demand for blood gas tests has also increased. Spurt in number of such tests is translating into burgeoning potential for the makers of blood gas analyzers. Demand is expected to emanate from the developing market, including Asia-Pacific, which is forecast to witness a CAGR of about 3.9% during the analysis period.
Segment-wise, blood gas analyzers constitutes the largest segment compared to electrolyte analyzers. In the blood gas analyzers market, although benchtop analyzers constitute a tad smaller share compared to the Point-of-Care (POC) analyzers in terms of units, they account for a major share in value terms. This reflects the cost-effectiveness and an increased adoption of POC analyzers, which is forecast to grow at a compounded annual growth of more than 5.5% in unit terms over the analysis period. In order to cope with the onslaught of POC devices, benchtop manufacturers are devising ways to reduce the bulkiness of central laboratory-based analyzers, and bringing them to near-patient sites, on par with point-of-care monitors. Other players in the benchtop market are foraying into the more lucrative POC arena.
The blood gas and electrolyte analyzers market, of late, has also seen the addition of several new testing parameters to test menus to include electrolytes, blood urea nitrogen, creatinine, and the like. This allows for drawing a single sample for multiple tests, resulting in minimal patient inconvenience, and saves time for healthcare providers. For manufacturers, this translates into increased revenues from improved seals of disposable cartridge, with different test menus. In addition, there is an increased popularity of combined analyzers. Combined analyzers are capable of performing the function of both blood gas analyzers and electrolyte analyzers, extending their use in testing a single sample for electrolytes, blood urea nitrogen, and creatinine.
Major players profiled in the report include Abaxis Inc., Abbott Point-of-Care, Beckman Coulter Inc., Hemagen Diagnostics Inc., IDEXX Laboratories Inc., OPTI Medical Systems Inc., Instrumentation Laboratory, Medica Corporation, Nova Biomedical Corporation, Radiometer A/S, Roche Diagnostics Ltd., Siemens Healthcare Diagnostics, Inc., among others.
The research report titled “Blood Gas and Electrolyte Analyzers: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the blood gas and electrolyte analyzers markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for Blood Gas and Electrolyte Analyzers market for the years 2009 through 2017 for the following geographic markets – United States, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Key product segments analyzed include Blood Gas Analyzers (Benchtop Analyzers and Point-of-Care Analyzers); and Electrolyte Analyzers. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/